Decheng Capital LLC 13F holdings, Q2 2025
Holdings as of June 30, 2025 · filings on SEC EDGAR · latest filing →
Decheng Capital LLC disclosed 25 US equity positions worth $396.0m in its Q2 2025 13F filing. The largest position was CGON at 41.8% of the reported book, followed by AARD and NUVB. Against the Q1 2025 filing, it opened 1 new position, added to 3 and reduced 8 among the top 25 holdings.
What did Decheng Capital LLC own in Q2 2025? Top 25 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2025 |
|---|---|---|---|---|---|---|---|
| 1 | CGON CG ONCOLOGY INC | Healthcare | 41.8% | $165.7m | 6,371,669 | 0% | held |
| 2 | AARD AARDVARK THERAPEUTICS INC | 13.4% | $53.0m | 3,917,299 | 0% | held | |
| 3 | NUVB Nuvation Bio Inc. | Healthcare | 12.8% | $50.6m | 25,954,439 | 0% | held |
| 4 | UPB Upstream Bio Inc. | 9.1% | $36.1m | 3,285,293 | 0% | held | |
| 5 | NEWAMSTERDAM PHARMA CO NV | 3.5% | $13.9m | 770,000 | 0% | held | |
| 6 | BYSI BeyondSpring Inc. | 2.7% | $10.6m | 4,531,481 | -7% | reduced | |
| 7 | MERUS NV | 2.5% | $9.9m | 189,098 | 0% | held | |
| 8 | KRYS KRYSTAL BIOTECH INC | Healthcare | 2.3% | $9.1m | 66,000 | 2% | added |
| 9 | MOONLAKE IMMUNOTHERAPEUTICS | 2.2% | $8.6m | 181,600 | 6% | added | |
| 10 | RVMD REVOLUTION MEDICINES INC(NSM) | Healthcare | 2.1% | $8.3m | 226,000 | 0% | held |
| 11 | ACRS Aclaris Therapeutics, Inc. | Healthcare | 1.4% | $5.7m | 4,041,736 | 0% | held |
| 12 | LYEL Lyell Immunopharma, Inc. | 1.3% | $5.3m | 595,466 | -95% | reduced | |
| 13 | ACLXGBX ARCELLX INC | 1.1% | $4.5m | 547,609 | 995% | added | |
| 14 | CRNXGBP CRINETICS PHARMACEUTICALS IN | 1.0% | $4.1m | 143,000 | -20% | reduced | |
| 15 | AURA Aura Biosciences, Inc. | 0.8% | $3.2m | 515,555 | 0% | held | |
| 16 | ZNTL Zentalis Pharmaceuticals Inc. | Healthcare | 0.4% | $1.5m | 1,323,327 | -34% | reduced |
| 17 | EQ Equillium Inc. | 0.4% | $1.4m | 4,447,308 | 0% | held | |
| 18 | FDMT 4D MOLECULAR THERAPEUTICS IN | 0.2% | $888.6k | 239,510 | -29% | reduced | |
| 19 | RCUS Arcus Biosciences, Inc | Healthcare | 0.2% | $811.2k | 160,000 | -80% | reduced |
| 20 | ILMN Illumnia, Inc. | Healthcare | 0.2% | $761.3k | 7,979 | -32% | reduced |
| 21 | LEGN LEGEND BIOTECH CORP-ADR | Healthcare | 0.2% | $709.8k | 20,000 | -80% | reduced |
| 22 | GRAL GRAIL INC | 0.1% | $498.0k | 9,684 | 0% | held | |
| 23 | PYXS Pyxis Oncology, Inc (formerly Apexigen) | 0.1% | $359.5k | 326,810 | 0% | held | |
| 24 | RZLT REZOLUTE INC | 0.1% | $267.2k | 59,900 | – | new | |
| 25 | Nuvation Bio Inc. | 0.0% | $127.3k | 646,057 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.